It's Time To Focus In On My Next Big Breakout Idea... This new profile is a clinical-stage biopharmaceutical company trading on the NYSE.

StockWireNews

One Analyst Shares This $.25 NYSE Stock Has Approximately 1,500% Potential Upside (Multiple Price Targets)

> Full Report Released 9:30AM EST Today <

(Do Right Now) SMS Update System Sign-up Info Below

January 13th

Good Morning,

It's Time To Focus In On My Next Big Breakout Idea...

This new profile is a clinical-stage biopharmaceutical company trading on the NYSE.

Current analyst provided price targets are painting crosshairs of tremendous upside potential on this company as it presently trades in the $.25 range.

The biggest price target is currently giving this company an approximate potential upside of 1,500%. Wow!

You know now that I think about it, many details of this new stock idea are starting to remind me of another recent runner with a significant analyst price target in NASDAQ champ CTXR.

Released in December at approximately $.60, biopharma stock CTXR cruised $.65 in one week for a high of $1.25 for a 108% surge.

With multiple analysts also chiming in on this new stock profile, it could be the next big breakout idea of 2020. You will not want to miss it!

To make sure you get this profile at 9:30AM EST today, do this right now:

image

-----

I'll be back to you shortly with your full report. Talk soon.

Sincerely,

Kai Parker

StockWireNews


(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

Disclosure: I am not a lice.nsed finan.cial adviser. All potential percentage gains are based on from the low to the high of day. StockWireNews full disclosure is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading Stock Wire News email or text newsletter you are agreeing to StockWireNews full disclosure which can be read at www.stockwirenews.net/disclosure Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com ("SCF") and an interest in the limited liability company that owns and operates fierce analyst . com ("FI"). From time to time, non-affiliated third parties hire Stock Wire News, SCF and/or FI jointly to publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between StockWireNews LLC and Venado Media LLC (a non affiliated 3rd party), StockWireNews was hired for a period beginning on 7/26/19 and ending on 7/29/19 to publicly disseminate information about (CTXR) via Website, Email and SMS. We were paid twenty thousand USD via bank wire transfer. We own zero shares of (CTXR). Pursuant to an agreement between StockWireNews LLC and Venado Media LLC (a non affiliated 3rd party), StockWireNews has been hired for a period beginning on 9/3/19 and ending on 9/4/19 to publicly disseminate information about (CTXR) via Website, Email and SMS. We were paid twenty thousand USD via bank wire transfer. We own zero shares of (CTXR). Pursuant to an agreement between StockWireNews LLC and Venado Media LLC (a non affiliated 3rd party), StockWireNews has been hired for a period beginning on 12/18/19 and ending on 12/19/19 to publicly disseminate information about (CTXR) via Website, Email and SMS. We were paid twenty thousand USD via bank wire transfer. We own zero shares of (CTXR). In total, we have been compensated sixty thousand USD via bank wire transfer to disseminate information about (CTXR).